Open Monoclonal Technology - Ownership and Business Overview

Life ScienceCompany

Open Monoclonal Technology Ownership

Who owns Open Monoclonal Technology?

Open Monoclonal Technology is owned by Ligand Pharmaceuticals. It was acquired on December 17, 2015.

Was Open Monoclonal Technology formerly PE-backed?

Yes. Open Monoclonal Technology was formerly owned by 1 private investor.

Open Monoclonal Technology Business Overview

Where is Open Monoclonal Technology headquartered?

Open Monoclonal Technology is headquartered in Palo Alto, California.

What sector is Open Monoclonal Technology in?

Open Monoclonal Technology is a life science company.

When was Open Monoclonal Technology founded?

Open Monoclonal Technology was founded in 2007.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Open Monoclonal Technology, Inc. (OMT)

2747 Ross Road, Suite A,
Palo Alto, California 94303
United States,
(650) 224-6835
www.openmonoclonaltechnology.com

Open Monoclonal Technology, Inc. (OMT) is a biotechnological company provides genetic engineering of animals for discovery of human therapeutic antibodies, naturally optimized human antibodies® and the only company with three transgenic animal platforms, collectively known as OmniAb™. All OmniAb platforms — OmniRat®, OmniMouse®, and OmniFlic™ — have broad freedom to operate, are protected by new patents and patent applications, and are available for all targets and indications


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.